Centre for Clinical Trials & Methodology, Institute of Population Health Sciences, Queen Mary University of London, London, UK.
MRC Clinical Trials Unit at University College London, London, UK.
Clin Trials. 2021 Apr;18(2):147-157. doi: 10.1177/1740774520976564. Epub 2021 Mar 8.
Cluster randomised trials, like individually randomised trials, may benefit from a baseline period of data collection. We consider trials in which clusters prospectively recruit or identify participants as a continuous process over a given calendar period, and ask whether and for how long investigators should collect baseline data as part of the trial, in order to maximise precision.
We show how to calculate and plot the variance of the treatment effect estimator for different lengths of baseline period in a range of scenarios, and offer general advice.
In some circumstances it is optimal not to include a baseline, while in others there is an optimal duration for the baseline. All other things being equal, the circumstances where it is preferable not to include a baseline period are those with a smaller recruitment rate, smaller intracluster correlation, greater decay in the intracluster correlation over time, or wider transition period between recruitment under control and intervention conditions.
The variance of the treatment effect estimator can be calculated numerically, and plotted against the duration of baseline to inform design. It would be of interest to extend these investigations to cluster randomised trial designs with more than two randomised sequences of control and intervention condition, including stepped wedge designs.
与个体随机试验一样,整群随机试验可能受益于基线数据收集期。我们考虑了在特定日历期间,以连续的方式前瞻性招募或确定参与者的试验,并询问调查人员是否以及应在多长时间内收集基线数据作为试验的一部分,以最大限度地提高精度。
我们展示了如何在各种情况下计算和绘制不同长度基线期的处理效果估计值的方差,并提供了一般性建议。
在某些情况下,不包括基线是最优的,而在其他情况下,基线的最佳持续时间是存在的。在所有其他条件相同的情况下,最好不包括基线期的情况是招募率较小、组内相关系数较小、组内相关系数随时间衰减较大,或在对照和干预条件下的招募过渡期较宽。
处理效果估计值的方差可以数值计算,并与基线期的持续时间进行对比,以提供设计信息。将这些研究扩展到具有多于两种对照和干预条件的随机序列的群组随机试验设计中,包括阶梯式楔形设计,将会很有趣。